|
PAK6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.788800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.391000E-01 |
| Normal-vs-Stage2 |
1.425430E-01 |
| Normal-vs-Stage3 |
4.431900E-02 |
| Normal-vs-Stage4 |
2.175600E-01 |
| Stage1-vs-Stage2 |
3.301400E-03 |
| Stage1-vs-Stage3 |
2.479400E-01 |
| Stage1-vs-Stage4 |
7.039800E-01 |
| Stage2-vs-Stage3 |
2.116900E-03 |
| Stage2-vs-Stage4 |
1.809610E-02 |
| Stage3-vs-Stage4 |
6.592600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.041750E-01 |
| Normal-vs-AfricanAmerican |
4.401600E-01 |
| Normal-vs-Asian |
1.662200E-01 |
| Caucasian-vs-AfricanAmerican |
4.954200E-02 |
| Caucasian-vs-Asian |
9.462600E-01 |
| AfricanAmerican-vs-Asian |
8.712100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.940800E-01 |
| Normal-vs-Female |
2.972000E-01 |
| Male-vs-Female |
8.132600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.056170E-01 |
| Normal-vs-Age(41-60Yrs) |
2.448200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.138800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.320500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.689400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.773700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.819200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.056630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.336800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.113790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.283900E-03 |
| Classical-VS-Follicular |
5.0878000035226E-08 |
| Classical-VS-Other |
9.959000E-01 |
| Classical-VS-Normal |
4.196000E-02 |
| Tall-VS-Follicular |
1.62490021438089E-10 |
| Tall-VS-Other |
1.860220E-01 |
| Tall-VS-Normal |
2.047300E-04 |
| Follicular-VS-Other |
7.984100E-02 |
| Follicular-VS-Normal |
5.179100E-03 |
| Other-VS-Normal |
3.893200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.404600E-01 |
| Normal-vs-N1 |
1.164370E-03 |
| N0-vs-N1 |
1.046360E-04 |
|
|
